Thursday, September 10, 2020 11:56:24 AM
This might have been already covered, but our own Board of Directors member Peter De Svastich is a Managing General Partner of Global Emerging Markets Limited (aka GEM).
Our own Board of Directors member Thomaz Burkhardt was on the Board of Directors of Bachem AG until April 2020. He had been a director of Bachem since 1997, but the bylaws required that his time serving was up: https://www.bachem.com/fileadmin/user_upload/pdf/Press_Release/2020/Press_Release_Change_Board_of_Directors_EN.pdf
Our own Board of Directors member Thomaz Burkhardt was on the Board of Directors of Bachem AG until April 2020. He had been a director of Bachem since 1997, but the bylaws required that his time serving was up: https://www.bachem.com/fileadmin/user_upload/pdf/Press_Release/2020/Press_Release_Change_Board_of_Directors_EN.pdf
Recent RLFTF News
- MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank • ACCESS Newswire • 03/19/2026 06:35:00 AM
- MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics • ACCESS Newswire • 12/23/2025 06:20:00 AM
- Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics • ACCESS Newswire • 12/15/2025 06:20:00 AM
- Relief Therapeutics Shareholders Approve Business Combination with NeuroX • ACCESS Newswire • 11/14/2025 05:40:00 PM
- Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032 • ACCESS Newswire • 10/29/2025 06:20:00 AM
